Muriaticum Acidum 6 X Drops ; Globules ; Granules is a Health Canada–registered human drug (DIN 02234050) held by Homeocan Inc., containing Hydrochloric Acid. Health Canada lists its status as Cancelled Post Market (status date 04 Aug 2009). Nexara Health has matched 7 registrations of Hydrochloric Acid across 2 other regulated markets, 2 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02234050 |
|---|---|
| Brand name | Muriaticum Acidum |
| Active ingredient | Hydrochloric Acid |
| Strength | 6 X |
| Dosage form | Drops ; Globules ; Granules |
| Route | Oral |
| Company | Homeocan Inc. |
| Status | Cancelled Post Market — 04 Aug 2009 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Hydrochloric Acid registered in other markets
7 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Acidum Hydrochloricum Dilutum "Y.y." | 應元化學製藥股份有限公司 | 內服液劑 | 已註銷 | TFDA | |
| United States | Hydrochloric Acid | Detrex Corporation | Liquid | FDA NDC | ||
| United States | Muriaticum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Muriaticum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Muriaticum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Muriaticum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Muriaticum acidum | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Hydrochloric Acid worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Muriaticum Acidum (DIN 02234050) marketed in Canada?
No. Health Canada lists DIN 02234050 as Cancelled Post Market as of 04 Aug 2009.
Who holds the Canadian licence for this product?
Homeocan Inc. is the company of record in the Health Canada Drug Product Database.
Is Hydrochloric Acid registered outside Canada?
Yes — Nexara Health has matched 7 registrations in 2 other markets, including 2 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02234050, status date 2009-08-04; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02234050, status date 2009-08-04; national medicine registries: FDA NDC, TFDA.
Health Canada Drug Product Database (DPD), DIN 02234050, status date 2009-08-04; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.